EGFR and colorectal carcinoma: Next, we knocked down CUL4B in CRC cells while simultaneously overexpressing either NSUN2‐WT or NSUN2‐DM and evaluated the changes in the ErbB signalling pathway and malignant phenotype of CRC cells.